C

Cadrenal Therapeutics Inc
NASDAQ:CVKD

Watchlist Manager
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Watchlist
Price: 7.37 USD -7.18% Market Closed
Market Cap: 15.3m USD

Relative Value

There is not enough data to reliably calculate the relative value of CVKD.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CVKD Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.9
Industry
21.7
Forward
-1.1
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.3
Industry
16.7
vs History
vs Industry
Median 3Y
-3.3
Median 5Y
-3.3
Industry
23.1
vs History
5
vs Industry
15
Median 3Y
1.9
Median 5Y
1.9
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
13.2
Forward
-0.7
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
16.8
Forward
-0.7
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-2.4
Industry
15.9
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-2.4
Industry
19.2
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-11.3
Industry
1.9

Multiples Across Competitors

CVKD Competitors Multiples
Cadrenal Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cadrenal Therapeutics Inc
NASDAQ:CVKD
15.2m USD 0 -1.1 -0.8 -0.8
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.7 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
502.4B USD 5.5 20 16.4 21.2
CH
Roche Holding AG
SIX:ROG
258.5B CHF 4.2 27.4 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212.4B GBP 4.9 30.2 108.5 158.7
CH
Novartis AG
SIX:NOVN
207B CHF 4.7 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
251.9B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.2 10.7
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
144B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
US
C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Average P/E: 23.9
Negative Multiple: -1.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.7
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.4
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Average EV/EBITDA: 438.8
Negative Multiple: -0.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.7
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.5
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Average EV/EBIT: 1 881.3
Negative Multiple: -0.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.2
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
1%
10.7
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3